Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium: The REDUCE Randomized Clinical Trial

JAMA : the Journal of the American Medical Association
Mark van den BoogaardGerjon Hannink

Abstract

Results of studies on use of prophylactic haloperidol in critically ill adults are inconclusive, especially in patients at high risk of delirium. To determine whether prophylactic use of haloperidol improves survival among critically ill adults at high risk of delirium, which was defined as an anticipated intensive care unit (ICU) stay of at least 2 days. Randomized, double-blind, placebo-controlled investigator-driven study involving 1789 critically ill adults treated at 21 ICUs, at which nonpharmacological interventions for delirium prevention are routinely used in the Netherlands. Patients without delirium whose expected ICU stay was at least a day were included. Recruitment was from July 2013 to December 2016 and follow-up was conducted at 90 days with the final follow-up on March 1, 2017. Patients received prophylactic treatment 3 times daily intravenously either 1 mg (n = 350) or 2 mg (n = 732) of haloperidol or placebo (n = 707), consisting of 0.9% sodium chloride. The primary outcome was the number of days that patients survived in 28 days. There were 15 secondary outcomes, including delirium incidence, 28-day delirium-free and coma-free days, duration of mechanical ventilation, and ICU and hospital length of stay. All ...Continue Reading

Citations

Mar 13, 2018·American Journal of Respiratory and Critical Care Medicine·Erin Nuzzo, Timothy D Girard
May 16, 2018·Critical Care Medicine·Rakesh C Arora, Colm Cunningham
Oct 17, 2018·Acta Anaesthesiologica Scandinavica·Laura Krone LarsenIngrid Egerod
Oct 23, 2018·The New England Journal of Medicine·Thomas P Bleck
Nov 18, 2018·Critical Care Medicine·Robert D Stevens, Elizabeth K Zink
Nov 22, 2018·Journal of the American Geriatrics Society·Babar A KhanKenneth Kesler
Dec 7, 2018·Critical Care Medicine·Cameron GreenRavindranath Tiruvoipati
Jan 29, 2019·Journal of Neurosurgical Anesthesiology·Jeffrey J Pasternak
Mar 30, 2019·Journal of Palliative Medicine·Paul A RiordanJason A Webb
Sep 3, 2019·Annals of Internal Medicine·Esther S OhKarin J Neufeld
Dec 7, 2019·Internal Medicine Journal·Michael C Reade
Nov 27, 2019·Critical Care Medicine·Babar A KhanMalaz A Boustani
Apr 16, 2019·Current Opinion in Critical Care·Christina S BoncykChristopher G Hughes
Mar 3, 2020·American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses·Sikandar H KhanBabar A Khan
Mar 12, 2020·Expert Opinion on Pharmacotherapy·Angela Scicutella
Feb 6, 2020·Anesthesia and Analgesia·Christopher G HughesUNKNOWN Perioperative Quality Initiative (POQI) 6 Workgroup
Aug 14, 2020·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Lauren E SchmidtJoanna L Stollings
Aug 25, 2020·Current Sleep Medicine Reports·Sadaf FarasatBiren B Kamdar
Feb 3, 2019·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·Anne L Donovan, Elizabeth L Whitlock
Apr 9, 2019·Journal of Pharmacy Practice·Pamela L Smithburger, Mona K Patel
Nov 15, 2019·Current Treatment Options in Neurology·Michael E Reznik, Arjen J C Slooter
Apr 22, 2020·Critical Care : the Official Journal of the Critical Care Forum·Matthew S DupreyJohn W Devlin
Jun 25, 2020·Critical Care : the Official Journal of the Critical Care Forum·Lauren J Andrews, Scott T Benken
Jul 22, 2018·JAMA : the Journal of the American Medical Association·Heather Torbic, Abhijit Duggal
Jun 25, 2018·Intensive Care Medicine·Nicola Latronico
Jul 22, 2018·JAMA : the Journal of the American Medical Association·Jacqueline J M H Strik, Jan N M Schieveld
Aug 26, 2018·Intensive Care Medicine·Anne W van SchijndelPeter H J van der Voort
Mar 19, 2019·The Journal of Clinical Investigation·Benjamin H Singer
Jan 27, 2019·Journal of the American Geriatrics Society·Babar A KhanMalaz A Boustani
Jul 26, 2018·Intensive Care Medicine·Jorge I F Salluh, Nicola Latronico
Nov 30, 2018·The Cochrane Database of Systematic Reviews·Suzanne Forsyth HerlingThordis Thomsen
Oct 10, 2018·Der Anaesthesist·N ZorembaG Schälte
Apr 9, 2019·American Journal of Respiratory and Critical Care Medicine·Ivor S DouglasHayley B Gershengorn
Oct 3, 2020·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Roma Dhamanaskar, Jon F Merz
Sep 22, 2020·Seminars in Respiratory and Critical Care Medicine·Yahya ShehabiBelinda Howe
Jun 27, 2019·World Journal of Critical Care Medicine·Marco CascellaRaffaela Di Napoli
May 21, 2019·F1000Research·Phillip Vlisides, Michael Avidan
Apr 30, 2020·Critical Care : the Official Journal of the Critical Care Forum·Katarzyna KotfisE Wesley Ely

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

JAMA : the Journal of the American Medical Association
Yu KawazoeDexmedetomidine for Sepsis in Intensive Care Unit Randomized Evaluation (DESIRE) Trial Investigators
JAMA : the Journal of the American Medical Association
Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART) InvestigatorsCarlos Roberto Ribeiro de Carvalho
© 2022 Meta ULC. All rights reserved